Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,448 | -29,893 | -13,541 | -21,581 | -11,105 |
| Depreciation Amortization | 24,563 | 18,769 | 9,384 | 26,268 | 18,906 |
| Accounts receivable | -87,187 | -6,970 | -12,172 | -6,457 | 2,719 |
| Other Working Capital | -20,489 | 4,468 | -10,099 | 5,204 | -2,103 |
| Other Operating Activity | 103,347 | 20,179 | 13,890 | 22,974 | 6,443 |
| Operating Cash Flow | $1,786 | $6,553 | $-12,538 | $26,408 | $14,860 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -5,513 | -1,701 | -2,935 | -48,911 | -50,029 |
| Net Acquisitions | -8,174 | -8,174 | N/A | N/A | N/A |
| Investing Cash Flow | $-13,687 | $-9,875 | $-2,935 | $-48,911 | $-50,029 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -187 | -180 | -111 | -350 | -291 |
| Financing Cash Flow | $-187 | $-180 | $-111 | $-350 | $-291 |
| Beginning Cash Position | 50,588 | 50,588 | 50,588 | 73,441 | 73,441 |
| End Cash Position | 38,500 | 47,086 | 35,004 | 50,588 | 37,981 |
| Net Cash Flow | $-12,088 | $-3,502 | $-15,584 | $-22,853 | $-35,460 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,786 | 6,553 | -12,538 | 26,408 | 14,860 |
| Free Cash Flow | 1,786 | 6,553 | -12,538 | 26,408 | 14,860 |